AMAG Pharma (AMAG) Posts Q3 Loss of $1.29
AMAG Hot Sheet
EPS Growth %: +7.4%Financial Fact:
Total costs and expenses: 28.29M
Today's EPS Names:
VSNT, CIM, KH, More
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) reports Q3 loss of $1.29, versus the analyst estimate of ($1.47). Revenue for the quarter was $ million, which compares to the estimate of $3.04 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Infoblox (BLOX) Tops Q3 EPS by 4c; Guides Q4
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
